
Alpha Tau Medical (NASDAQ: DRTS)
Alpha Tau Medical Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Alpha Tau Medical Company Info
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company. It focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
News & Analysis
Why Alpha Tau Medical Stock Skyrocketed Today
The stock enjoyed another big gain.
Why Alpha Tau Medical Ltd. Stock Soared 42% on Wednesday
The company is developing a promising type of radiation treatment for solid tumors.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.